ClinicalTrials.gov record
Terminated Phase 3 Interventional

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00060671

Public ClinicalTrials.gov record NCT00060671. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 6:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Randomized, Phase III Comparative Trial of BBR 2778 + Rituximab Versus Rituximab in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NHL)

Study identification

NCT ID
NCT00060671
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CTI BioPharma
Industry
Enrollment
800 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Dec 31, 2005
Completion
Dec 31, 2005
Last update posted
Jan 18, 2015

2005 – 2006

United States locations

U.S. sites
38
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Arizona Clinical Research Center Tucson Arizona 85712
Sutter Health Western Division Cancer Research Group Greenbrae California 94904
Kenmar Research Institute Los Angeles California 90057
Rocky Moutain Cancer Center Denver Colorado 80218
Pasco, Hernando Oncology Associates, P.A. New Port Richey Florida
Ocala Oncology Center Ocala Florida 34474
Orange Park Cancer Center Orange Park Florida 32073
University of Chicago Medical Center Hematology / Oncology Chicago Illinois 60637
Illinois Masonic Cancer Center Chicago Illinois 60657
Edward Cancer Center Naperville Illinois 60540
Hope Center Terre Haute Indiana 47802
Commonwealth Hematology/Oncology Danville Kentucky 40422
New England Hematology / Oncology Associates Wellesley Massachusetts 02481
St. Joseph Oncology Saint Joseph Missouri 64507
Christian Hospital St Louis Missouri 63136
St. Johns Mercy Medical Center St Louis Missouri 63141
Hematology - Oncology Centers of N. Rockies Billings Montana 59101
Great Falls Clinic Great Falls Montana 59405
East Orange VA Medical Center East Orange New Jersey 07018
Hematology Oncology Associates of NJ Paramus New Jersey 07652
Summit Medical Group/Overlook Onc Center Summit New Jersey 07901
New Mexico Oncology / Hematology Albuquerque New Mexico 87109
HemOnCare, P.C. Brooklyn New York 11235
Glens Falls Cancer Center Glens Falls New York 12801
North Shore - Long Island Jewish Health System New Hyde Park New York 11040
New York University New York New York 10016
Upstate NY Cancer Research Rochester New York 14623
South Shore Hematology-Oncology Associates Rockville Centre New York 11570
Clinworks, Inc Charlotte North Carolina
Private Practice Canton Ohio 44718
Blair Medical Associates Altoona Pennsylvania 16601
Lancaster Cancer Center, LTD Lancaster Pennsylvania 17605
Santee Hematology Oncology Sumter South Carolina 29150
The West Clinic Memphis Tennessee 38120
Central Utah Medical Clinic Hematology-Oncology Provo Utah 84604
Oncology of Wisconsin Glendale Wisconsin 53212
Marshfield Clinic Marshfield Wisconsin 54449
Rhinelander Regional Medical Group Onc. Rhinelander Wisconsin 54501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00060671, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2015 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00060671 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →